Thema
Journal Article
49
Research Support, Non-U.S. Gov't
14
Anti-Bacterial Agents
12
COVID-19
8
Multicenter Study
8
Bacteremia
7
Outcome
7
Randomized Controlled Trial
6
SARS-CoV-2
6
615
5
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
5
Letter
5
che
5
61036-62-2
4
808UI9MS5K
4
Observational Study
4
Teicoplanin
4
dalbavancin
4
4QWG6N8QKH
3
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
3
Antibiotic therapy
3
Antimicrobial resistance
3
Antiviral Agents
3
Bacteremia of unknown origin
3
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
3
Case Reports
3
Cellulitis
3
Community-acquired infection
3
Dalbavancin
3
Drug Combinations
3
Empirical antibiotic therapy
3
Empirical antibiotic treatment
3
Erysipelas
3
Guidelines
3
Hydroxychloroquine
3
Primary bacteremia
3
SSTI
3
Severe sepsis
3
bio
3
remdesivir
3
3QKI37EEHE
2
415SHH325A
2
74469-00-4
2
83905-01-5
2
Acyclovir
2
Adenosine Monophosphate
2
Alanine
2
Amoxicillin-Potassium Clavulanate Combination
2
Antibiotic
2
Antimicrobial stewardship
2
mehr ...